Holmium laser enucleation of the prostate for treatment for large-sized benign prostate hyperplasia; is it a realistic endourologic alternative in developing country?
Autor: | Tamer S. Barakat, Mahmoud Laymon, Ahmed R. El-Nahas, Mohamed M. Elsaadany, Ahmed M. Elshal, Ramy Mekkawy, Ahmed El-Assmy |
---|---|
Rok vydání: | 2015 |
Předmět: |
Male
Reoperation Nephrology medicine.medical_specialty Blood transfusion Urology medicine.medical_treatment Enucleation Prostatic Hyperplasia 030232 urology & nephrology Lasers Solid-State 03 medical and health sciences 0302 clinical medicine Urine flow rate Prostate Internal medicine medicine Humans Prospective Studies Developing Countries Neoplasm Staging business.industry Prostatectomy Incidence Transurethral Resection of Prostate Hyperplasia medicine.disease Treatment Outcome medicine.anatomical_structure 030220 oncology & carcinogenesis Egypt Laser Therapy business Follow-Up Studies Open Prostatectomy |
Zdroj: | World Journal of Urology. 34:399-405 |
ISSN: | 1433-8726 0724-4983 |
DOI: | 10.1007/s00345-015-1639-8 |
Popis: | To assess the functional outcome and cumulative health-resource-related cost of holmium laser enucleation of the prostate (HoLEP) in comparison with transvesical open prostatectomy (TVOP) in a developing country. Matching of 92 HoLEP and 91 TVOP procedures was performed using resected prostate tissue weight as a sole matching criterion. Safety, efficacy, and accordingly health-related cost-efficiency of both procedures were statistically compared. Preoperative criteria and mean prostate size (166.7 ± 49.7, 161.4 ± 35.7 ml) were similar in HoLEP and TVOP, respectively; however, HoLEP treated more comorbid patients. Blood transfusion was 2.1 and 26.1 % after HoLEP and TVOP, respectively (P = 0.001). Median time to catheter removal and hospital stay was 2 days after HoLEP and 5 and 9 days, respectively, after TVOP (P |
Databáze: | OpenAIRE |
Externí odkaz: |